Chemoinformaics analysis of (1S,3R,4Sm5R)-1,3,4,5- Tetrahydroxycyclohexanecarboxylic acid
| Molecular Weight | 192.167 | nRot | 1 |
| Heavy Atom Molecular Weight | 180.071 | nRig | 7 |
| Exact Molecular Weight | 192.063 | nRing | 1 |
| Solubility: LogS | -0.397 | nHRing | 0 |
| Solubility: LogP | -1.94 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 24.5035 |
| nHD | 5 | BPOL | 12.9065 |
| QED | 0.318 |
| Synth | 3.598 |
| Natural Product Likeliness | 2.249 |
| NR-PPAR-gamma | 0.009 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.137 |
| HIA | 0.893 |
| CACO-2 | -6.115 |
| MDCK | 0.00684161 |
| BBB | 0.831 |
| PPB | 0.121355 |
| VDSS | 0.459 |
| FU | 0.725219 |
| CYP1A2-inh | 0.018 |
| CYP1A2-sub | 0.053 |
| CYP2c19-inh | 0.007 |
| CYP2c19-sub | 0.054 |
| CYP2c9-inh | 0.002 |
| CYP2c9-sub | 0.068 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.107 |
| CYP3a4-inh | 0.017 |
| CYP3a4-sub | 0.01 |
| CL | 1.556 |
| T12 | 0.671 |
| hERG | 0.019 |
| Ames | 0.031 |
| ROA | 0.011 |
| SkinSen | 0.031 |
| Carcinogencity | 0.005 |
| EI | 0.282 |
| Respiratory | 0.019 |
| NR-Aromatase | 0.003 |
| Antiviral | No |
| Prediction | 0.926131 |